SOUTH SAN FRANCISCO, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...

Altamira Therapeutics Ltd. Annual stock financials by MarketWatch. View the latest CYTOF financial statements, income statements and financial ratios.

Owing to its complexity and interactions with peripheral cells, the brain is a difficult organ to study. Scientists require sensitive, high-dimensional techniques, such as cytometry by time of flight ...

Mass cytometry, with detection by TOF, has been a transformative single-cell technology in immunology, immunophenotyping, oncology and infectious disease studies for a decade. It is in use in over 150 ...

Using cytometry by time of flight (CyTOF) technology, researchers measure multiple parameters for comprehensive cell phenotyping and functional analyses. This capability is especially important when ...

Immune escape mechanisms such as the induction/recruitment of immunosuppressive cells and the increased expression of various immunosuppressive molecules including PD-1/PD-1 ligands are essential ...

SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

Altamira Therapeutics Ltd (CYTOF) is making significant progress in its RNA delivery business, focusing on nanoparticle formulation and process development. The company has successfully developed ...